← Back to Clinical Trials
Recruiting NCT06966518

Intraoperative Combination of Ketamine and Magnesium Sulfate Infusions on Postoperative Analgesia in Open Rhinoplasty

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Intraoperative
Sponsor Ain Shams University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2025-05-12
Completion 2025-10-01
Interventions
Ketamine and Magnesium SulfateSaline 0.9%

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The study aims to evaluate the effectiveness of intraoperative combination of ketamine and magnesium sulfate infusions on postoperative analgesia in patients undergoing open rhinoplasty.

Eligibility Criteria

Inclusion Criteria: * Age from 18 to 65 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I - II. * Scheduled for rhinoplasty under general anesthesia. Exclusion Criteria: * Receiving analgesic or any medications since 48 hours before the surgery. * Drug addiction. * Cardiovascular disease. * Respiratory disease, renal, liver, metabolic and neurological disease. * Pregnancy or breast feeding. * Asthma.

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE INTRAOPERATIVE TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}